ISPOR 2024 Home
Toggle navigation
About
News Center
Award Winners
Program
Program
Learning Formats
Plenary Sessions
Posters
Program Committee
Digital Conference Pass
Exhibits & Sponsorship
Sponsor List
Exhibitor Directory
Media Partners
Photo Gallery
ISPOR
2024
May 5-8, 2024
Home
Events
Past Conferences
ISPOR 2024
Program
Plenary Sessions
Session
Tirzepatide and Weight Reduction Among Individuals without Evidence of Type 2 Diabetes: Descriptive Results from Optum’s De-Identified Market Clarity Data
May 7, 2024, 16:30 PM
«
771
772
773
774
775
776
(current)
777
778
779
780
»